Got a female patient affected by a bleeding disorder? Haemophilia Foundation Australia wants to hear from them.
A critical gap in understanding and addressing bleeding disorders in women and girls is being tackled with the launch of a new national survey by Haemophilia Foundation Australia (HFA). This initiative arrives at a crucial time, as awareness of the unique challenges faced by female patients – often misdiagnosed or experiencing delayed diagnosis – is steadily growing within the medical community.
- Addressing a Diagnostic Gap: The survey aims to pinpoint the barriers women and girls face in receiving accurate and timely diagnoses for bleeding disorders.
- Patient-Centered Insights: HFA is actively seeking information on what resources and tools empower patients to advocate for themselves effectively within healthcare settings.
- Long-Term Impact: Survey data will directly inform the HFA’s Women and Girls Advisory Group, shaping future programs, education, and research priorities.
For decades, bleeding disorders like haemophilia have been largely considered “male” conditions, leading to significant underdiagnosis and misdiagnosis in females. While traditionally understood as affecting primarily males (who inherit the condition via the X chromosome), females can also be affected – either through inheriting the condition directly or, more commonly, as carriers of the gene. Crucially, the HFA highlights that 20-30% of carriers experience reduced clotting factor levels, resulting in clinically significant bleeding symptoms. This underscores the need to move beyond the outdated perception of these disorders as exclusively male.
The survey’s focus on the patient experience – specifically, how women and girls navigate healthcare interactions – is particularly noteworthy. It acknowledges the systemic issues that can lead to dismissal of symptoms, particularly those related to menstruation, as simply “normal” female experiences. Collecting data on the usefulness of tools like patient cards and period diaries is a practical step towards empowering patients to actively participate in their own care and advocate for their needs.
The Forward Look
The HFA’s initiative is likely to spur a broader conversation about gender bias in medical diagnosis and treatment. We can anticipate increased scrutiny of medical training curricula to ensure adequate coverage of bleeding disorders in females, and a push for more sensitive and nuanced questioning practices by healthcare professionals. The data collected will be instrumental in developing targeted educational materials for both patients and clinicians. Furthermore, the findings could influence future research funding priorities, directing more resources towards understanding the specific manifestations of bleeding disorders in women and girls, and developing tailored treatment strategies. The closing date of April 8, 2026, provides a substantial timeframe for data collection and analysis, suggesting the HFA intends to conduct a thorough and impactful study. Expect a detailed report, and subsequent advocacy efforts, to emerge in late 2026 and early 2027, potentially leading to revised clinical guidelines and improved patient outcomes.
Anyone interested in learning more about the survey can contact HFA on 03 9885 7800 or at [email protected].
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
